Literature DB >> 11496244

Decline of CD3-positive T-cell counts by 6 months of age is associated with rapid disease progression in HIV-1--infected infants.

J Chinen1, K A Easley, H Mendez, W T Shearer.   

Abstract

Because HIV-1 infected infants with rapid progression (RP) of disease might benefit from early and intense antiretroviral therapy, the identification of predictive factors of RP becomes extremely important. Currently, the best predictive factors of RP in HIV-1 infected children are HIV-1 RNA levels and CD4-positive T-cell counts. A decrease in CD3-positive T-cell count has been identified as a predictive factor of AIDS development in HIV-1 infected adults. Our objective was to evaluate decreased number of CD3-positive T-cells as a predictive factor of RP in infants. Peripheral blood lymphocytes from HIV-1 infected infants (up to 6 months of age) were analyzed for an association of lymphocyte subsets with RP, which was defined as the occurrence of AIDS or death before 18 months of age. In infants with RP (n = 32), CD3-positive T-cell counts were 3093 cells/microL at <1 month of age, 3092 cells/microL at 1 to 3 months, and 2062 cells/microL at 3 to 6 months. Non-RP infants (n = 49) maintained their CD3-positive T-cells counts at approximately 4000 cells/microL for at least 6 months of life. CD3-positive and CD4-positive T-cell counts were significantly associated with RP. Our results suggest that a decreased CD3-positive T-cell count may be used to predict RP in HIV-1 infected infants (RR = 2.16, P =.001).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496244      PMCID: PMC4357165          DOI: 10.1067/mai.2001.116573

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group.

Authors:  W T Shearer; T C Quinn; P LaRussa; J F Lew; L Mofenson; S Almy; K Rich; E Handelsman; C Diaz; M Pagano; V Smeriglio; L A Kalish
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

2.  Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group.

Authors:  W T Shearer; S E Lipshultz; K A Easley; K McIntosh; J Pitt; T C Quinn; M Kattan; J Goldfarb; E Cooper; Y Bryson; A Kovacs; J T Bricker; H Peavy; R B Mellins; N Heart; L B Institute
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

3.  Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group.

Authors:  W T Shearer; K A Easley; J Goldfarb; H M Rosenblatt; H B Jenson; A Kovacs; K McIntosh
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

4.  The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Authors:  L M Mofenson; J Korelitz; W A Meyer; J Bethel; K Rich; S Pahwa; J Moye; R Nugent; J Read
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

5.  Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.

Authors:  K Luzuriaga; R A Koup; C A Pikora; D B Brettler; J L Sullivan
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

6.  Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.

Authors:  M J Mayaux; M Burgard; J P Teglas; J Cottalorda; A Krivine; F Simon; J Puel; C Tamalet; D Dormont; B Masquelier; A Doussin; C Rouzioux; S Blanche
Journal:  JAMA       Date:  1996-02-28       Impact factor: 56.272

7.  Decline in total T cell count is associated with onset of AIDS, independent of CD4(+) lymphocyte count: implications for AIDS pathogenesis.

Authors:  J B Margolick; A D Donnenberg; C Chu; M R O'Gorman; J V Giorgi; A Muñoz
Journal:  Clin Immunol Immunopathol       Date:  1998-09
  7 in total
  2 in total

1.  CD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study.

Authors:  Savita Pahwa; Jennifer S Read; Wanrong Yin; Yvonne Matthews; William Shearer; Clemente Diaz; Kenneth Rich; Hermann Mendez; Bruce Thompson
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

2.  CD4/CD8 T-cell ratio predicts HIV infection in infants: the National Heart, Lung, and Blood Institute P2C2 Study.

Authors:  William T Shearer; Savita Pahwa; Jennifer S Read; Jian Chen; Sameera R Wijayawardana; Paul Palumbo; Elaine J Abrams; Stephen R Nesheim; Wanrong Yin; Bruce Thompson; Kirk A Easley
Journal:  J Allergy Clin Immunol       Date:  2007-10-17       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.